{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:25:47Z","timestamp":1780673147143,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82300996"],"award-info":[{"award-number":["No.82300996"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82300996"],"award-info":[{"award-number":["No.82300996"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82300996"],"award-info":[{"award-number":["No.82300996"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Talent Cultivation Fund of the First Affiliated Hospital of Nanchang University","award":["YFYPY202235"],"award-info":[{"award-number":["YFYPY202235"]}]},{"name":"Young Talent Cultivation Fund of the First Affiliated Hospital of Nanchang University","award":["YFYPY202235"],"award-info":[{"award-number":["YFYPY202235"]}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Natural Science Foundation","doi-asserted-by":"crossref","award":["20202BABL206037"],"award-info":[{"award-number":["20202BABL206037"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangxi Natural Science Foundation for Youths","award":["20232BAB216030"],"award-info":[{"award-number":["20232BAB216030"]}]},{"name":"Jiangxi Natural Science Foundation for Youths","award":["20232BAB216030"],"award-info":[{"award-number":["20232BAB216030"]}]},{"name":"Jiangxi Natural Science Foundation for Youths","award":["20232BAB216030"],"award-info":[{"award-number":["20232BAB216030"]}]},{"name":"Jiangxi Province Chinese Medicine Science and Technology Program General Project","award":["2023B1394"],"award-info":[{"award-number":["2023B1394"]}]},{"name":"Jiangxi Province Chinese Medicine Science and Technology Program General Project","award":["2023B1394"],"award-info":[{"award-number":["2023B1394"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82360440"],"award-info":[{"award-number":["No.82360440"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteoarthritis (OA) is a common degenerative joint condition marked by inflammation and cartilage breakdown. Currently, there is a dearth of treatment medications that can clearly slow the course of OA. Glaucocalyxin A (GLA) is a diterpene chemical identified and extracted from Rabdosia japonica with antithrombotic, anticoagulant, anti-tumor, anti-inflammatory, anti-oxidant, and other pharmacological properties. Previous research has linked inflammation to abnormalities in the homeostasis of the extracellular matrix (ECM). Although GLA has been shown to have anti-inflammatory qualities, its effects on the progression of OA are unknown. As a result, the goal of this study was to see if GLA could slow the course of OA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>ATDC5 cells were stimulated by IL-1\u03b2 to create an inflammatory chondrocyte damage model. Quantitative polymerase chain reaction, Western Blot, high-density culture, and immunofluorescence were used to detect the expression levels of associated gene phenotypes. We also created a mouse model of OA induced by destabilization of the medial meniscus (DMM) instability, and GLA was administered intraperitoneally once every two days for eight weeks. Mice knee specimens were stained with hematoxylin\u2013eosin, Safranin O\/fast green, and immunohistochemical, and the Osteoarthritis Research Society International grade system and Mankin\u2019s score were used to assess the protective effect of GLA on cartilage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In vitro and in vivo, we explored the effects and molecular processes of GLA as a therapy for OA. The findings demonstrated that GLA might reduce the expression of associated inflammatory mediators and protect the ECM by inhibiting the NF-\u03baB and MAPK signaling pathways. Animal research revealed that GLA could protect against the DMM-induced OA model mice by stabilizing ECM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Taken together, our findings show that GLA has a protective impact on cartilage throughout OA progression, implying that GLA could be employed as a possible therapeutic agent for OA, thus giving a new therapeutic method for the treatment of OA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-024-04640-z","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T14:01:49Z","timestamp":1710770509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Glaucocalyxin A delays the progression of OA by inhibiting NF-\u03baB and MAPK signaling pathways"],"prefix":"10.1186","volume":"19","author":[{"given":"Xin","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoujie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meisong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"issue":"10182","key":"4640_CR1","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745\u201359.","journal-title":"Lancet"},{"issue":"11","key":"4640_CR2","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nrrheum.2016.148","volume":"12","author":"SR Goldring","year":"2016","unstructured":"Goldring SR, Goldring MB. Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol. 2016;12(11):632\u201344.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"4640_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/BOR.0b013e328349c2b1","volume":"23","author":"MB Goldring","year":"2011","unstructured":"Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011;23(5):471\u20138.","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"4640_CR4","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/eji.201141550","volume":"41","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA. A clinical perspective of IL-1beta as the gatekeeper of inflammation. Eur J Immunol. 2011;41(5):1203\u201317.","journal-title":"Eur J Immunol"},{"issue":"10","key":"4640_CR5","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.joca.2008.03.009","volume":"16","author":"N Chabane","year":"2008","unstructured":"Chabane N, et al. Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Osteoarthr Cartil. 2008;16(10):1267\u201374.","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"4640_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jor.22577","volume":"32","author":"YJ Chen","year":"2014","unstructured":"Chen YJ, et al. Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes. J Orthop Res. 2014;32(4):573\u201380.","journal-title":"J Orthop Res"},{"issue":"26","key":"4640_CR7","doi-asserted-by":"publisher","first-page":"19819","DOI":"10.1074\/jbc.M002079200","volume":"275","author":"C Miyaura","year":"2000","unstructured":"Miyaura C, et al. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice. J Biol Chem. 2000;275(26):19819\u201323.","journal-title":"J Biol Chem"},{"issue":"5","key":"4640_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1242\/dev.105536","volume":"142","author":"E Kozhemyakina","year":"2015","unstructured":"Kozhemyakina E, Lassar AB, Zelzer E. A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation. Development. 2015;142(5):817\u201331.","journal-title":"Development"},{"key":"4640_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jphs.2015.04.005","volume":"128","author":"P Gan","year":"2015","unstructured":"Gan P, et al. Anti-inflammatory effects of glaucocalyxin B in microglia cells. J Pharmacol Sci. 2015;128:35\u201346.","journal-title":"J Pharmacol Sci"},{"issue":"4","key":"4640_CR10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.7150\/ijbs.23602","volume":"14","author":"L Wenfeng","year":"2018","unstructured":"Wenfeng L, et al. Glaucocalyxin A induces G2\/M cell cycle arrest and apoptosis through the PI3K\/Akt pathway in human bladder cancer cells. Int J Biol Sci. 2018;14(4):418\u201326.","journal-title":"Int J Biol Sci"},{"key":"4640_CR11","doi-asserted-by":"publisher","first-page":"114176","DOI":"10.1016\/j.jep.2021.114176","volume":"276","author":"M Zhu","year":"2021","unstructured":"Zhu M, et al. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-\u03baB and Akt pathways. J Ethnopharmacol. 2021;276:114176.","journal-title":"J Ethnopharmacol"},{"key":"4640_CR12","doi-asserted-by":"publisher","first-page":"119185","DOI":"10.1016\/j.lfs.2021.119185","volume":"271","author":"J Chen","year":"2021","unstructured":"Chen J, et al. Glaucocalyxin A induces cell cycle arrest and apoptosis via inhibiting NF-kappaB\/p65 signaling pathway in melanoma cells. Life Sci. 2021;271:119185.","journal-title":"Life Sci"},{"issue":"24","key":"4640_CR13","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1080\/14786419.2014.934235","volume":"28","author":"Z Xiang","year":"2014","unstructured":"Xiang Z, et al. Glaucocalyxin A: a review. Nat Prod Res. 2014;28(24):2221\u201336.","journal-title":"Nat Prod Res"},{"key":"4640_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cbi.2019.05.005","volume":"307","author":"X Jiang","year":"2019","unstructured":"Jiang X, et al. Glaucocalyxin A reverses EMT and TGF-beta1-induced EMT by inhibiting TGF-beta1\/Smad2\/3 signaling pathway in osteosarcoma. Chem Biol Interact. 2019;307:158\u201366.","journal-title":"Chem Biol Interact"},{"key":"4640_CR15","doi-asserted-by":"publisher","first-page":"963689720967672","DOI":"10.1177\/0963689720967672","volume":"29","author":"Z Peng","year":"2020","unstructured":"Peng Z, et al. Glaucocalyxin A protects H9c2 cells against hypoxia\/reoxygenation-induced injury through the activation of Akt\/Nrf2\/HO-1 pathway. Cell Transplant. 2020;29:963689720967672.","journal-title":"Cell Transplant"},{"issue":"1","key":"4640_CR16","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1515\/med-2022-0513","volume":"17","author":"S Chen","year":"2022","unstructured":"Chen S, et al. Protective effects of glaucocalyxin A on the airway of asthmatic mice. Open Med (Wars). 2022;17(1):1158\u201371.","journal-title":"Open Med (Wars)"},{"key":"4640_CR17","doi-asserted-by":"publisher","first-page":"106271","DOI":"10.1016\/j.intimp.2020.106271","volume":"81","author":"X Hou","year":"2020","unstructured":"Hou X, et al. Glaucocalyxin A alleviates LPS-mediated septic shock and inflammation via inhibiting NLRP3 inflammasome activation. Int Immunopharmacol. 2020;81:106271.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"4640_CR18","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.joca.2007.03.006","volume":"15","author":"SS Glasson","year":"2007","unstructured":"Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129\/SvEv mouse. Osteoarthr Cartil. 2007;15(9):1061\u20139.","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"4640_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","volume":"14","author":"KP Pritzker","year":"2006","unstructured":"Pritzker KP, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil. 2006;14(1):13\u201329.","journal-title":"Osteoarthr Cartil"},{"issue":"14","key":"4640_CR20","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2174\/1381612824666180327165604","volume":"24","author":"YT Yeung","year":"2018","unstructured":"Yeung YT, et al. Signaling pathways in inflammation and anti-inflammatory therapies. Curr Pharm Des. 2018;24(14):1449\u201384.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"4640_CR21","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"46","key":"4640_CR22","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.1038\/sj.onc.1208842","volume":"24","author":"H Kasperczyk","year":"2005","unstructured":"Kasperczyk H, et al. Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy. Oncogene. 2005;24(46):6945\u201356.","journal-title":"Oncogene"},{"key":"4640_CR23","doi-asserted-by":"publisher","first-page":"16072","DOI":"10.1038\/nrdp.2016.72","volume":"2","author":"J Martel-Pelletier","year":"2016","unstructured":"Martel-Pelletier J, et al. Osteoarthritis. Nat Rev Dis Primers. 2016;2:16072.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4640_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.joca.2021.05.007","volume":"30","author":"VP Leifer","year":"2022","unstructured":"Leifer VP, Katz JN, Losina E. The burden of OA-health services and economics. Osteoarthr Cartil. 2022;30(1):10\u20136.","journal-title":"Osteoarthr Cartil"},{"issue":"28","key":"4640_CR25","doi-asserted-by":"publisher","first-page":"11742","DOI":"10.1073\/pnas.0610812104","volume":"104","author":"J Zwerina","year":"2007","unstructured":"Zwerina J, et al. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci U S A. 2007;104(28):11742\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"4640_CR26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","volume":"12","author":"WH Robinson","year":"2016","unstructured":"Robinson WH, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(10):580\u201392.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"4640_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1055\/s-0037-1615821","volume":"31","author":"AE Cook","year":"2018","unstructured":"Cook AE, Cook JL, Stoker AM. Metabolic responses of meniscus to IL-1beta. J Knee Surg. 2018;31(9):834\u201340.","journal-title":"J Knee Surg"},{"issue":"3","key":"4640_CR28","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1039\/C7FO01892D","volume":"9","author":"G Zheng","year":"2018","unstructured":"Zheng G, et al. Monascin inhibits IL-1beta induced catabolism in mouse chondrocytes and ameliorates murine osteoarthritis. Food Funct. 2018;9(3):1454\u201364.","journal-title":"Food Funct"},{"issue":"43","key":"4640_CR29","doi-asserted-by":"publisher","first-page":"16898","DOI":"10.1073\/pnas.0702761104","volume":"104","author":"LA Ridnour","year":"2007","unstructured":"Ridnour LA, et al. Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways. Proc Natl Acad Sci U S A. 2007;104(43):16898\u2013903.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4640_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","volume":"17","author":"MD Sternlicht","year":"2001","unstructured":"Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463\u2013516.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"4640_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41413-022-00201-4","volume":"10","author":"W Jiang","year":"2022","unstructured":"Jiang W, et al. PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis. Bone Res. 2022;10(1):27.","journal-title":"Bone Res"},{"key":"4640_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41413-019-0071-x","volume":"7","author":"M Tu","year":"2019","unstructured":"Tu M, et al. Inhibition of cyclooxygenase-2 activity in subchondral bone modifies a subtype of osteoarthritis. Bone Res. 2019;7:29.","journal-title":"Bone Res"},{"issue":"18","key":"4640_CR33","doi-asserted-by":"publisher","first-page":"096368972096767","DOI":"10.1177\/0963689720967672","volume":"29","author":"Z Peng","year":"2020","unstructured":"Peng Z, et al. Glaucocalyxin A protects H9c2 cells against hypoxia\/reoxygenation-induced injury through the activation of Akt\/Nrf2\/HO-1 pathway. Cell Transplant. 2020;29(18):096368972096767.","journal-title":"Cell Transplant"},{"issue":"1","key":"4640_CR34","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/ijms23010446","volume":"23","author":"K Hosohata","year":"2021","unstructured":"Hosohata K, Jin D, Takai S. Glaucocalyxin A ameliorates hypoxia\/reoxygenation-induced injury in human renal proximal tubular epithelial cell line HK-2 cells. Int J Mol Sci. 2021;23(1):446.","journal-title":"Int J Mol Sci"},{"key":"4640_CR35","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.biopha.2018.09.161","volume":"109","author":"J Fei","year":"2019","unstructured":"Fei J, et al. Luteolin inhibits IL-1beta-induced in fl ammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model. Biomed Pharmacother. 2019;109:1586\u201392.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"4640_CR36","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.apsb.2019.01.015","volume":"9","author":"F Zhou","year":"2019","unstructured":"Zhou F, et al. Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-kappaB\/MAPK signaling and protecting chondrocytes. Acta Pharm Sin B. 2019;9(5):973\u201385.","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"4640_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cbpa.2005.04.004","volume":"9","author":"GL Johnson","year":"2005","unstructured":"Johnson GL, Dohlman HG, Graves LM. MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression. Curr Opin Chem Biol. 2005;9(3):325\u201331.","journal-title":"Curr Opin Chem Biol"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-024-04640-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-024-04640-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-024-04640-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T14:05:08Z","timestamp":1710770708000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-024-04640-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4640"],"URL":"https:\/\/doi.org\/10.1186\/s13018-024-04640-z","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]},"assertion":[{"value":"30 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Joint Committee on Medical Ethics of Nanchang University authorized the animal research for this trial (No.DM20210912).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We certify that there is no conflicts between our interests in this study or the research findings.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}